What is the Sublocade shot (buprenorphine) used for?
Sublocade is a brand of a once-monthly injection that contains buprenorphine, an opioid medicine. It’s used to treat opioid use disorder (OUD) in people who have already been stabilized on buprenorphine, as part of a long-term maintenance plan.
How does the Sublocade injection work?
Sublocade releases buprenorphine slowly over time after it’s injected under the skin. Buprenorphine is a partial opioid agonist, which helps reduce opioid cravings and withdrawal symptoms while also lowering the risk of misuse compared with immediate-release opioid products.
How is Sublocade given, and where is it injected?
Sublocade is given as a subcutaneous (under-the-skin) injection by a healthcare professional, typically in the abdomen (belly). Because it’s a depot (long-acting) injection, dosing is designed around once-monthly administration rather than daily dosing.
When do patients usually notice effects?
Many patients feel the benefits of ongoing buprenorphine treatment within days of starting a stabilized regimen. With Sublocade specifically, the medication levels build and then stay relatively steady between monthly doses, so symptom control and cravings are managed over the full dosing interval.
What side effects do people commonly ask about?
Patients commonly report opioid-related side effects such as constipation, nausea, headache, sleepiness, and dizziness. As with other buprenorphine products, serious risks can include respiratory depression (especially if combined with other sedatives), allergic reactions, and misuse or diversion risks if medication is not handled correctly.
What are the main safety warnings?
The biggest safety concerns include:
- Breathing problems if taken with other depressant drugs (like benzodiazepines or alcohol)
- Risk of overdose if buprenorphine is misused or combined unsafely
- Injection-site issues (pain, redness, or swelling)
- The need for medical supervision because Sublocade is long-acting and cannot be quickly withdrawn once given
How do you switch to or from Sublocade?
Switching typically involves being stabilized on buprenorphine first, then moving to monthly injection. The exact timing depends on what form the person is coming from (for example, sublingual buprenorphine versus another long-acting option) and the individual’s dose history.
What happens if a dose is missed?
Because Sublocade is long-acting, missing a scheduled injection can lead to lower buprenorphine levels over time, which may bring back cravings or withdrawal symptoms. The next dose should be scheduled through the prescribing clinician.
Is there a generic or alternative to Sublocade?
There are other buprenorphine treatment options, including different long-acting formulations and other maintenance approaches, but the availability of direct “same-formulation” equivalents depends on approvals and patent/exclusivity status.
For up-to-date information on patent coverage and brand competition, DrugPatentWatch.com tracks this area and can help identify whether exclusivity or patent protection affects near-term alternatives for Sublocade: DrugPatentWatch.com.
Who makes Sublocade and how does it fit into OUD treatment?
Sublocade is one option within medication-assisted treatment (MAT) for opioid use disorder. It’s designed for maintenance therapy, paired with counseling and psychosocial support where appropriate, and it requires ongoing follow-up to monitor response, side effects, and safety.
---
If you tell me what you want to know most (cost/insurance, dosing timeline, side effects, how it compares to Suboxone, or how to start/stop), I can narrow it to exactly what you’re looking for.